Journal
JOURNAL OF EXPERIMENTAL MEDICINE
Volume 213, Issue 6, Pages 1011-1028Publisher
ROCKEFELLER UNIV PRESS
DOI: 10.1084/jem.20151183
Keywords
-
Categories
Funding
- Institut National de la Sante et de la Recherche Medicale
- Institut National du Cancer [PLBI011-151]
- Imagine Institut [ANR-10-IAHU-01]
- European Research Council [ERC-2009-AdG_20090506, FP7-249816]
- Ligue Contre le Cancer (Equipe Labelisee LA LIGUE)
Ask authors/readers for more resources
Inherited bone marrow failure syndromes are human conditions in which one or several cell lineages of the hemopoietic system are affected. They are present at birth or may develop progressively. They are sometimes accompanied by other developmental anomalies. Three main molecular causes have been recognized to result in bone marrow failure syndromes: (1) defects in the Fanconi anemia (FA)/BRCA DNA repair pathway, (2) defects in telomere maintenance, and (3) abnormal ribosome biogenesis. We analyzed a patient with mild bone marrow failure and microcephaly who did not present with the typical FA phenotype. Cells from this patient showed increased sensitivity to ionizing radiations and phleomycin, attesting to a probable DNA double strand break (dsb) repair defect. Linkage analysis and whole exome sequencing revealed a homozygous nonsense mutation in the ERCC6L2 gene. We identified a new ERCC6L2 alternative transcript encoding the DNA repair factor Hebo, which is critical for complementation of the patient's DNAdsb repair defect. Sequence analysis revealed three structured regions within Hebo: a TUDOR domain, an adenosine triphosphatase domain, and a new domain, HEBO, specifically present in Hebo direct orthologues. Hebo is ubiquitously expressed, localized in the nucleus, and rapidly recruited to DNAdsb's in an NBS1-dependent manner.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available